摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tert-butyl (3-([1,1'-biphenyl]-4-yl)propyl)carbamate | 872215-01-5

中文名称
——
中文别名
——
英文名称
tert-butyl (3-([1,1'-biphenyl]-4-yl)propyl)carbamate
英文别名
tert-butyl N-[3-(4-phenylphenyl)propyl]carbamate
tert-butyl (3-([1,1'-biphenyl]-4-yl)propyl)carbamate化学式
CAS
872215-01-5
化学式
C20H25NO2
mdl
——
分子量
311.424
InChiKey
GROYJUVUUXNNIQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.81
  • 重原子数:
    23.0
  • 可旋转键数:
    5.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.35
  • 拓扑面积:
    38.33
  • 氢给体数:
    1.0
  • 氢受体数:
    2.0

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    A new type of ketolides bearing an N-aryl-alkyl acetamide moiety at the C-9 iminoether synthesis and structure–activity relationships
    摘要:
    A new type of ketolides, bearing an N-aryl-alkyl acetamide moiety at the C-9 iminoether and a cyclic carbonate at the G 11, 12 position was prepared and the antibacterial activities of the compounds were evaluated. Some of the derivatives showed potent antibacterial activity against both Haemophilus influenzae and Streptococcus pneumoniae, which are clinically important respiratory tract pathogens. Among the derivatives prepared, compound 5s with a quinolin-4-yl moiety was found to have potent and well-balanced activity against S. pneumoniae and H. influenzae including erythromycin-resistant strains. (c) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2005.07.041
  • 作为产物:
    参考文献:
    名称:
    A new type of ketolides bearing an N-aryl-alkyl acetamide moiety at the C-9 iminoether synthesis and structure–activity relationships
    摘要:
    A new type of ketolides, bearing an N-aryl-alkyl acetamide moiety at the C-9 iminoether and a cyclic carbonate at the G 11, 12 position was prepared and the antibacterial activities of the compounds were evaluated. Some of the derivatives showed potent antibacterial activity against both Haemophilus influenzae and Streptococcus pneumoniae, which are clinically important respiratory tract pathogens. Among the derivatives prepared, compound 5s with a quinolin-4-yl moiety was found to have potent and well-balanced activity against S. pneumoniae and H. influenzae including erythromycin-resistant strains. (c) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2005.07.041
点击查看最新优质反应信息

文献信息

  • Photocatalytic Carboxylation of C−N Bonds in Cyclic Amines with CO <sub>2</sub> by Consecutive Visible‐Light‐Induced Electron Transfer
    作者:Lin Chen、Quan Qu、Chuan‐Kun Ran、Wei Wang、Wei Zhang、Yi He、Li‐Li Liao、Jian‐Heng Ye、Da‐Gang Yu
    DOI:10.1002/anie.202217918
    日期:2023.3.6
    A photocatalytic carboxylation of C−N bonds in cyclic amines with CO2 is realized by consecutive photo-induced electron transfer (ConPET). This mild and transition-metal-free protocol provides a general and practical route to valuable β-, γ-, δ- and ϵ-amino acids.
    通过连续光诱导电子转移 (ConPET) 实现环胺中 C-N 键与 CO 2的光催化羧化。这种温和且不含过渡属的方案为有价值的 β-、γ-、δ- 和 ε- 氨基酸提供了一条通用且实用的途径。
  • Selective synthesis of functionalized linear aliphatic primary amines <i>via</i> decarboxylative radical-polar crossover
    作者:Robin Cauwenbergh、Prakash Kumar Sahoo、Rakesh Maiti、Abra Mathew、Rositha Kuniyil、Shoubhik Das
    DOI:10.1039/d3gc03187j
    日期:——
    Although photoredox catalysis is already known for synthesizing amines, the synthesis of linear aliphatic amines is mostly limited to hydroaminomethylation (HAM) reactions and has never been applied to the synthesis of longer-chain linear aliphatic primary amines. Considering this, the synthesis of functionalized linear aliphatic primary amines is demonstrated by using the decarboxylative radical-polar
    脂肪族伯胺至关重要,每年至少需要数百万吨。因此,人们对寻找新的合成化学路线产生了浓厚的兴趣。此外,为了符合可持续性要求,高度优先考虑使用廉价原料的合成路线。在这方面,由于烯烃的广泛可用性和较低的价格,加氢基烷基化(HAA)反应是非常理想的。尽管光氧化还原催化已知用于合成胺,但直链脂肪胺的合成主要限于加氢甲基化(HAM)反应,并且从未应用于长链直链脂肪伯胺的合成。考虑到这一点,通过使用脱羧自由基-极性交叉工艺证明了官能化直链脂肪伯胺的合成,该方法以优异的收率产生了多种官能化直链脂肪胺。该方法的优势通过现有药物的合成和复杂药物的后期转化得到证明,并通过详细的机理研究进行了阐述。
  • (Phenoxyimine)nickel-Catalyzed C(sp2)–C(sp3) Suzuki–Miyaura Cross-Coupling: Evidence for a Recovering Radical Chain Mechanism
    作者:L. Reginald Mills、Eric M. Simmons、Heejun Lee、Eva Nester、Junho Kim、Steven R. Wisniewski、Matthew V. Pecoraro、Paul J. Chirik
    DOI:10.1021/jacs.4c01474
    日期:2024.4.10
    the C(sp2)–C(sp3) Suzuki–Miyaura cross coupling of (hetero)arylboronic acids with alkyl bromides. With 5 mol % of the optimal (MeOMeFI)Ni(Aryl)(DMAP) precatalyst, the scope of the cross-coupling reaction was established and included a variety of (hetero)arylboronic acids and alkyl bromides (>50 examples, 33–97% yield). A β-hydride elimination–reductive elimination sequence from reaction with potassium
    合成了苯氧亚胺 (FI)–(II)(2-甲苯基)(DMAP) 化合物,并作为(杂)芳基硼酸与烷基的 C(sp 2 )–C(sp 3 ) Suzuki-Miyaura 交叉偶联的预催化剂进行了评估化物。使用 5 mol% 的最佳 (Me OMe FI)Ni(芳基)(DMAP) 预催化剂,建立了交叉偶联反应的范围,包括各种(杂)芳基硼酸和烷基(> 50 个示例,33 –97% 的产率)。与异丙醇钾碱反应产生 (FI) (0) 酸的 β-氢化物消除-还原消除序列被确定为负责从烷基中提取卤素原子的催化剂活化途径。 NMR 和 EPR 光谱相结合,确定 (FI) (II)-芳基配合物在催化过程中处于静止状态,没有证据表明存在长寿命有机自由基或奇电子中间体。这些数据表明,自由基链是短暂的,很容易终止,并且还支持“恢复自由基链”过程,通过该过程,(FI)(II)-芳基化合物不断地(
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫